EnzymeBioSystems
Las Vegas, US · Nevada corporation
Founders & leadership
GR
Gary RojewskiNamed on SEC filing
JD
John Dean HarperNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$779.5K disclosed across 2 rounds · 2017
▶$389.8KraisedOct 2017 · 15 investors · PharmaceuticalsRule 506(c)
▶$389.8KraisedOct 2017 · 15 investors · Pharmaceuticals
Rule 506(c)Officers, directors & promoters on the filing
- Gary RojewskiExecutive Officer, Director
- John Dean HarperDirector
- Offering amount
- $3M
- Amount sold
- $389.8K
- Minimum investment
- $1K
- Proceeds to insiders
- $50K
- First sale
- Sep 2017
- Incorporated
- Corporation, Nevada
- Federal exemptions
- 06c
▶$389.8KraisedOct 2017 · 15 investors · PharmaceuticalsRule 506(c)
▶$389.8KraisedOct 2017 · 15 investors · Pharmaceuticals
Rule 506(c)Officers, directors & promoters on the filing
- Gary RojewskiExecutive Officer, Director
- John Dean HarperDirector
- Offering amount
- $3M
- Amount sold
- $389.8K
- Minimum investment
- $1K
- Proceeds to insiders
- $50K
- First sale
- Sep 2017
- Incorporated
- Corporation, Nevada
- Federal exemptions
- 06c
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has EnzymeBioSystems raised?
- EnzymeBioSystems has disclosed $779.5K raised across 2 rounds.
- Where is EnzymeBioSystems headquartered?
- EnzymeBioSystems is headquartered in Las Vegas, US.